InterCure has incorporated its "Interactive Respiratory-Pacing" technology into product lines that offer non-drug treatments for hypertension and heart failure. Their first market-ready product, RESPeRATE, is an FDA-cleared medical device that lowers high blood pressure with no side effects. Additionally, their heart failure product, InTone™, has completed phase 2a clinical trials and is awaiting regulatory approval. With a strong management team and scientific advisory board, InterCure aims to become a market leader in patient-focused medical devices for chronic conditions. The company was founded in 1994 and is headquartered in Ra'anana, Israel.